Evidence map›Paper›PMID 30485762›Full record

ReviewAnnual review of physiology2019

Cell Death in the Lung: The Apoptosis-Necroptosis Axis.

Maor Sauler, Isabel S Bazan, Patty J Lee

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Annual review of physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 189 papers.

0numbers the graph read from it
0cells of the map it votes in
189citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05787288 early_phase1unknown statusnot on this mapstarted 2023, after this paper: background citation

Clinical Study on the Safety and Efficacy of Mesenchymal Stem Cell Exosomes in the Treatment of Coronavirus Infection.

TypeinterventionalSponsorFirst Affiliated Hospital of Wenzhou Medical UniversityRan2023 to 2025Enrolled240ConditionsCOVID-19 PneumoniaArmsExtracellular Vesicles from Mesenchymal Stem Cells
NCT05808400 early_phase1unknown statusnot on this mapstarted 2023, after this paper: background citation

Clinical Study of the Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Exosomes in Treating Chronic Cough After COVID-19 Infection

TypeinterventionalSponsorHuazhong University of Science and TechnologyRan2023 to 2025Enrolled80ConditionsLong COVID-19 SyndromeArmsMSC-derived exosomes
3 · Its place in the literature

Who cites it

189 citing papers in PubMed.

  1. Trial
  2. Trial
  3. The emerging roles of disulfidptosis in cancer.Apoptosis : an international journal on programmed cell death · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. When clearance fails: the role of efferocytosis in COPD.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  18. Article
  19. Article
  20. Review

129 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maor SaulerDepartment of Medicine, Yale School of Medicine, New Haven, Connecticut 06520, USA; email: patty.lee@yale.edu.
Isabel S BazanDepartment of Medicine, Yale School of Medicine, New Haven, Connecticut 06520, USA; email: patty.lee@yale.edu.
Patty J LeeDepartment of Medicine, Yale School of Medicine, New Haven, Connecticut 06520, USA; email: patty.lee@yale.edu.

Funding

Training Translational Lung Biology and PathobiologyT32HL007778 · NHLBI · YALE UNIVERSITY · PI Erica L Herzog, NAFTALI KAMINSKI · 1994 to 2026
$14.4M
TLR4-MEDIATED EPIGENETIC AND SENESCENCE MECHANISMS IN EMPHYSEMAR01HL138396 · NHLBI · YALE UNIVERSITY · PI LEE, PATTY J · 2017 to 2020
$1.5M
MIF and DNA repair in the emphysematous lungK08HL135402 · NHLBI · YALE UNIVERSITY · PI SAULER, MAOR · 2017 to 2021
$842k
TLR4-Mediated Mechanisms of Lung AgingR56HL126519 · NHLBI · YALE UNIVERSITY · PI LEE, PATTY J · 2015 to 2015
$403k
MIF-mediated Mechanisms in EmphysemaI01BX003265 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI PATTY J LEE · 2017 to 2026
–
BLRD VA I01 BX003265NHLBI NIH HHS K08 HL135402NHLBI NIH HHS R01 HL138396NHLBI NIH HHS R56 HL126519NHLBI NIH HHS T32 HL007778
6 · The paper itself

Abstract

Regulated cell death is a major mechanism to eliminate damaged, infected, or superfluous cells. Previously, apoptosis was thought to be the only regulated cell death mechanism; however, new modalities of caspase-independent regulated cell death have been identified, including necroptosis, pyroptosis, and autophagic cell death. As an understanding of the cellular mechanisms that mediate regulated cell death continues to grow, there is increasing evidence that these pathways are implicated in the pathogenesis of many pulmonary disorders. This review summarizes our understanding of regulated cell death as it pertains to the pathogenesis of chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, acute respiratory distress syndrome, and pulmonary arterial hypertension.

Indexed as

Regulated Cell DeathAnimalsApoptosisAsthmaAutophagic Cell DeathHumansIdiopathic Pulmonary FibrosisLung DiseasesNecroptosisPulmonary Arterial HypertensionPulmonary Disease, Chronic ObstructivePyroptosisRespiratory Distress Syndromeacute respiratory distress syndromeapoptosisasthmachronic obstructive pulmonary diseaseidiopathic pulmonary fibrosisnecroptosispulmonary arterial hypertension

Identifiers

PMID30485762
PMCPMC6598441

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.